| 000 | 01592 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516063909.0 | ||
| 264 | 0 | _c20120820 | |
| 008 | 201208s 0 0 eng d | ||
| 022 | _a1945-0257 | ||
| 024 | 7 |
_a10.1089/gtmb.2011.0216 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEraltan, Hakan | |
| 245 | 0 | 0 |
_aMCP-1 and CCR2 gene variants and the risk for osteoporosis and osteopenia. _h[electronic resource] |
| 260 |
_bGenetic testing and molecular biomarkers _cApr 2012 |
||
| 300 |
_a229-33 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBone Diseases, Metabolic _xgenetics |
| 650 | 0 | 4 |
_aChemokine CCL2 _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Frequency |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xgenetics |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 | _aPostmenopause |
| 650 | 0 | 4 |
_aReceptors, CCR2 _xgenetics |
| 700 | 1 | _aCacina, Canan | |
| 700 | 1 | _aKahraman, Ozlem Timirci | |
| 700 | 1 | _aKurt, Ozlem | |
| 700 | 1 | _aAydogan, Hulya Yilmaz | |
| 700 | 1 | _aUyar, Mehmet | |
| 700 | 1 | _aCan, Ayşe | |
| 700 | 1 | _aCakmakoğlu, Bedia | |
| 773 | 0 |
_tGenetic testing and molecular biomarkers _gvol. 16 _gno. 4 _gp. 229-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1089/gtmb.2011.0216 _zAvailable from publisher's website |
| 999 |
_c21310276 _d21310276 |
||